NewAmsterdam Pharma Company N.V. (NAMS) Net margin 2022–2025
NewAmsterdam Pharma Company N.V. (NAMS) net profit margin by fiscal year — reported net income divided by reported revenue.
-905.7%FY2025 · since FY2022: -22.0% → -905.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -905.7% | -375.5 pp |
| FY2024 | -530.3% | +725.5 pp |
| FY2023 | -1255.8% | -1233.7 pp |
| FY2022 | -22.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice